Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Crossref DOI link: https://doi.org/10.1007/s10549-017-4155-2
Published Online: 2017-02-15
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goorts, Briete
van Nijnatten, Thiemo J. A.
de Munck, Linda
Moossdorff, Martine
Heuts, Esther M.
de Boer, Maaike
Lobbes, Marc B. I.
Smidt, Marjolein L.
License valid from 2017-02-15